Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
PharmaEssentia Secures Taiwan Approval of BESREMi for Essential Thrombocythaemia
Thursday, June 11, 2026PharmaEssentia has received approval from Taiwans Ministry of Health and Welfare MOHW for BESREMi ropeginterferon alfabnjft to treat adult patients with essential thrombocythaemia ET
Antengene Receives China IND Approval for ATG-201 Autoimmune Disease Study
Wednesday, June 10, 2026Antengene has received Investigational New Drug IND approval from Chinas National Medical Products Administration NMPA to begin the Phase I ATTRACT study of ATG a CD CD bispecific
Nxera Joins OpenFold AI Research Consortium to Strengthen Drug Discovery Capabilities
Wednesday, June 10, 2026Nxera Pharma has joined OpenFold a nonprofit artificial intelligence research consortium focused on developing opensource AI tools for biology and drug discovery
Everest Medicines Enters into Agreement with Vcare PharmaTech for Sumecigrel
Tuesday, June 09, 2026Everest Medicines has entered into an exclusive licensing agreement with Vcare PharmaTech for the development registration and commercialisation of Sumecigrel across the AsiaPacific region
Engitix and GSK Partner to Identify New Targets for Liver Fibrosis Regression
Tuesday, June 09, 2026Engitix has entered into a strategic research collaboration and option agreement with GSK to identify and validate novel therapeutic targets aimed at promoting liver fibrosis regression
Everest Medicines Enters into Agreement with Corxel Pharmaceuticals to Develop and Commercialise LNZ100
Monday, June 08, 2026Everest Medicines has entered into an asset purchase agreement with Corxel Pharmaceuticals to acquire the rights to develop manufacture and commercialise LNZ in Greater China including mainland China Hong Kong SAR Macao SAR and Taiwan
Roche and Nurix Therapeutics Partner to Advance BTK Degrader Bexobrutideg
Monday, June 08, 2026Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to codevelop and cocommercialise bexobrutideg NX an investigational Brutons Tyrosine Kinase BTK degrader
Stipple Bio Signs Licensing Agreement with Lonza for Precision Oncology ADC Development
Friday, June 05, 2026Stipple Bio has entered a multitarget licensing agreement with Lonza to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Friday, June 05, 2026Biogen announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen for the treatment of spinal muscular atrophy SMA
Chai Discovery Signs Licensing Agreement with Pfizer to Advance AI-Driven Drug Discovery
Friday, June 05, 2026Chai Discovery has entered into a licensing agreement with Pfizer to support the use of artificial intelligence in drug discovery and accelerate the development of new medicines
